期刊文献+

糖皮质激素用于严重脓毒血症及脓毒性休克患者抢救的临床价值 被引量:12

Clinical value of corticosteroids for rescue of patients with severe sepsis and septic shock
原文传递
导出
摘要 目的为提高临床治愈率,了解糖皮质激素在严重脓毒血症及脓毒性休克患者抢救治疗中的应用价值。方法选择2009年1月-2010年12月ICU 51例接受抢救的严重脓毒血症及脓毒性休克患者,单盲随机将其中的32例分为试验组,余者分为对照组。结果试验组患者休克治愈率为68.8%,升压药停用率为73.7%,休克治愈率和升压药停用率显著高于对照组,病死率为26.3%显著低于对照组,差异均有统计学意义(均P<0.05);试验组患者升压药停用时间、休克逆转时间及机械通气停用时间显著短于对照组,差异有统计学意义(P<0.05)。结论对于脓毒血症及脓毒性休克的患者,适量应用糖皮质激素,可提高休克治愈率,降低死亡率。 OBJECTIVE To improve the clinical cure rate and understand the application value of corticosteroids in treatment of patients with severe sepsis and septic shock. METHODS A total of 51 cases of patients with severe sepsis and septic shock,which were rescued in our department between Jan 2009 and Dec 2010 were selected.32 cases of patients were single-blind randomly divided into experimental group,and the remainder into control group. RESULTS The cure rate of shock of experimental groups of patients was 68.8%,and their discontinuation rate of pressor drugs was 73.7%.The cure rate of shock of and the discontinuation rate of experimental groups of patients were significantly higher than that of control groups of patients(P〈0.05),while fatality rate of experimental groups of patients was 26.3%,significantly lower than in control group(P〈0.05).The discontinuation time of pressor drugs,the reverse time of shock and the discontinuation time mechanical ventilation were significantly shorter than that in control group(P〈0.05). CONCLUSION For patients with severe sepsis and septic shock,compatibly using corticosteroids can improve the cure rate of shock,and reduce the fatality rate.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第22期4737-4739,共3页 Chinese Journal of Nosocomiology
关键词 糖皮质激素 严重脓毒血症 脓毒性休克 Corticosteroids Severe sepsis Septic shock
  • 相关文献

参考文献10

二级参考文献20

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2Antonelli M, Levy M, Andrews PJ,et al. Hemodynamic monitoring in shock and implications for management [ J ]. Intensive Care Med ,2007,33,575 - 590.
  • 3Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign:international guideline for management of severe sepsis and septic shock :2008 [ J ]. Intensive Care Med ,2008 ,34 ,17 - 60.
  • 4Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock [ J ]. N Engl J Med ,2001,345:1368 - 1377.
  • 5Blot F, Schmidt E, Nitenberg G, et al. Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter-related sepsis[ J ]. J Clin Microbiol, 1998,36 : 105 - 109.
  • 6Tenover FC. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond [ J ]. Clin Infect Dis, 2007,44:418 - 423.
  • 7Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa ( activated ) for adults with severe sepsis and a low risk of death[J]. N Engl J Med ,2005,353 : 1332 - 1341.
  • 8Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [ J ]. JAMA,2002,288 : 862 - 871.
  • 9Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock [ J ]. N Engl J Med,2008,358:11 -24.
  • 10Van den Berghe, Wouters PJ,Weekers F, et al. Intensive insulin therapy in critically ill patients [ J ]. N Engl J Med, 2001,345: 1359 - 1367.

共引文献95

同被引文献100

引证文献12

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部